BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/28/2025 7:32:56 AM | Browse: 265 | Download: 760
 |
Received |
|
2025-01-22 08:28 |
|
Peer-Review Started |
|
2025-01-22 08:28 |
|
First Decision by Editorial Office Director |
|
2025-03-19 23:00 |
|
Return for Revision |
|
2025-03-19 23:00 |
|
Revised |
|
2025-03-27 12:26 |
|
Publication Fee Transferred |
|
2025-03-31 12:48 |
|
Second Decision by Editor |
|
2025-05-07 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-05-07 05:56 |
|
Articles in Press |
|
2025-05-07 05:56 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-05-20 07:14 |
|
Publish the Manuscript Online |
|
2025-05-28 07:32 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Upadacitinib for ulcerative colitis and pyoderma gangrenosum in a patient with schizophrenia on long-term risperidone: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sheng-Duo He and Yu Tian |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yu Tian, Chief Physician, MD, Department of Gastroenterology, Peking University First Hospital, N0.8 xishiku street, xicheng district, Beijing 100034, China. tianyu@medmail.com.cn |
| Key Words |
Ulcerative colitis; Schizophrenia; Risperidone; Pyoderma gangrenosum; Upadacitinib; Case report |
| Core Tip |
Due to the potential anti-inflammatory effect of risperidone via the tumor necrosis factor pathway, patients with new-onset ulcerative colitis (UC) who have been receiving long-term risperidone cannot achieve a good therapeutic effect with anti-tumor necrosis factor therapy. We report the successful treatment of a patient with UC combined with pyoderma gangrenosum using upadacitinib, with no adverse events during the 6-month follow-up period. |
| Publish Date |
2025-05-28 07:32 |
| Citation |
He SD, Tian Y. Upadacitinib for ulcerative colitis and pyoderma gangrenosum in a patient with schizophrenia on long-term risperidone: A case report. World J Gastroenterol 2025; 31(20): 104038 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i20/104038.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i20.104038 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
